ASEPTIC (Primary Antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis) is an NIHR HTA funded multi-centre trial to examine the efficacy of primary prophylaxis using the narrow-spectrum antibiotic Co-Trimoxazole in patients with cirrhosis and ascites.

We are still looking for sites and the study will run for the next 4 years. Please contact the chief Investigator Alastair O’Brien via email for more details.